524804:BOM
Aurobindo Pharma Ltd
1 658,65 ₹
arrow_downward
-0,98%(-16,35) 1D
16 հոկ, 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 524804...
Open
1 683,55 ₹
High
1 683,55 ₹
Low
1 654,75 ₹
Mkt. cap
959,10 մլրդ
Avg. vol.
29,66 հզր
Volume
11,19 հզր
P/E ratio
25,92
52-wk high
1 739,95 ₹
52-wk low
1 080,10 ₹
EPS
64,00 ₹
Shares outstanding
585,90 մլն
No. of employees
29 հզր
Open
1 683,55 ₹
High
1 683,55 ₹
Low
1 654,75 ₹
Mkt. cap
959,10 մլրդ
Avg. vol.
29,66 հզր
Volume
11,19 հզր
P/E ratio
25,92
52-wk high
1 739,95 ₹
52-wk low
1 080,10 ₹
EPS
64,00 ₹
Shares outstanding
585,90 մլն
No. of employees
29 հզր
News stories
From web sources and news partners
Moneycontrol.com
·
3 օր առաջ
Aurobindo joins speciality pharma race as Indian drugmakers return to branded US play
Profile
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca. Wikipedia
About Aurobindo Pharma Ltd
CEO-
Employees29,2 հզր
Founded1986
HeadquartersՀայդերաբադ, Անդհրա-Պրադեշ, Հնդկաստան
Sector-
Websiteaurobindo.com